Home / Publications / European Patent Office (EPO) level of disclosure required...

European Patent Office (EPO) level of disclosure required for antibodies - first medical use

22/03/2023

As a complement to the 10th edition of the EPO "Case Law of the Boards of Appeal" (CLB), the EPO has published an Annual Review containing summaries of decisions from 2022. The review provides a thematic overview of selected decisions of the Boards of Appeal published...

Read more

Authors

Portrait ofJane Evenson
Jane Evenson
Partner
London
Portrait ofMarek Blaszyk
Marek Blaszyk
Trainee
London